老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enlivex Therapeutics Ltd.

0.1734
-0.0258-12.95%
盘后：0.18000.0066+3.81%19:58 EDT
成交量：65.90万
成交额：11.58万
市值：425.04万
市盈率：0.00
高：0.1831
开：0.1690
低：0.1690
收：0.1992
52周最高：27.15
52周最低：0.1690
股本：2,451.19万
流通股本：1,234.92万
量比：1.17
换手率：5.34%
股息：- -
股息率：- -
每股收益(TTM):279.32
每股收益(LYR):382.20
净资产收益率：162.86%
总资产收益率：-0.61%
市净率：0.00
市盈率(LYR):0.00

数据加载中...

总览公司新闻资讯公告
2020/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/31

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/23

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/05

SEC问询函

[Cover]Correspondence
2019/06/27

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/26

超过5%披露

Statement of acquisition of beneficial ownership by individuals
更多